Paper42436735
Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.
Etherton-Beer C and 9 others. Ther Adv Drug Saf, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study. Papers, record 42436735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42436735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34446273 | Anticholinergics and clinical outcomes amongst people with pre-existing dementia: A systematic review. | Maturitas | 2021 | https://conductscience.org/library/papers/34446273 | PubMed |
| 2 | 27288377 | Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. | BMJ Open | 2016 | https://conductscience.org/library/papers/27288377 | PubMed |
| 3 | 38307120 | Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis. | J Am Med Dir Assoc | 2024 | https://conductscience.org/library/papers/38307120 | PubMed |
| 4 | 3558716 | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. | J Chronic Dis | 1987 | https://conductscience.org/library/papers/3558716 | PubMed |
| 5 | 21479777 | Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). | Qual Life Res | 2011 | https://conductscience.org/library/papers/21479777 | PubMed |
| 6 | 25358236 | Comorbidity and dementia: a scoping review of the literature. | BMC Med | 2014 | https://conductscience.org/library/papers/25358236 | PubMed |
| 7 | 19647495 | Telephone interview for cognitive status: Creating a crosswalk with the Mini-Mental State Examination. | Alzheimers Dement | 2009 | https://conductscience.org/library/papers/19647495 | PubMed |
| 8 | 33639545 | Strategies to engage people with dementia and their informal caregivers in dyadic intervention: A scoping review. | Geriatr Nurs | 2021 | https://conductscience.org/library/papers/33639545 | PubMed |
| 9 | 34457093 | Home medicines reviews: a national survey of Australian accredited pharmacists' health service time investment. | Pharm Pract (Granada) | 2021 | https://conductscience.org/library/papers/34457093 | PubMed |
| 10 | 26338170 | Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review. | Curr Clin Pharmacol | 2015 | https://conductscience.org/library/papers/26338170 | PubMed |
| 11 | 37247404 | Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study. | Age Ageing | 2023 | https://conductscience.org/library/papers/37247404 | PubMed |
| 12 | 29327604 | Strategies to improve recruitment of people with dementia to research studies. | Dementia (London) | 2019 | https://conductscience.org/library/papers/29327604 | PubMed |
| 13 | 37213440 | Linking Patients' Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway. | J Patient Exp | 2023 | https://conductscience.org/library/papers/37213440 | PubMed |
| 14 | 31219179 | Polypharmacy among older Australians, 2006-2017: a population-based study. | Med J Aust | 2019 | https://conductscience.org/library/papers/31219179 | PubMed |
| 15 | 2760661 | Improving the sensitivity of the Barthel Index for stroke rehabilitation. | J Clin Epidemiol | 1989 | https://conductscience.org/library/papers/2760661 | PubMed |
| 16 | 17452540 | A drug burden index to define the functional burden of medications in older people. | Arch Intern Med | 2007 | https://conductscience.org/library/papers/17452540 | PubMed |
| 17 | 37603255 | Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER). | Drugs Aging | 2023 | https://conductscience.org/library/papers/37603255 | PubMed |
| 18 | 30373460 | Patient engagement in research related to dementia: A scoping review. | Dementia (London) | 2018 | https://conductscience.org/library/papers/30373460 | PubMed |
| 19 | 26530985 | A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. | Trials | 2015 | https://conductscience.org/library/papers/26530985 | PubMed |
| 20 | 29177770 | Interventions to Improve Medicines Management for People with Dementia: A Systematic Review. | Drugs Aging | 2017 | https://conductscience.org/library/papers/29177770 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42436735
GET https://conductscience.org/api/papers/v1/42436735/references?page=2